Industry Research Reports

Home > Reports > Pharma & Healthcare > Global Varicella Vaccine Market Research Report 2025

Global Varicella Vaccine Market Research Report 2025

Industry: Pharma & Healthcare

Published Date: 2025-01-16

Pages: 80 Pages

Report ld: 3466290

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Varicella Vaccine Market Size(US$)

CAGR 2025-2031

7.8%

Market Size,2031

USD 8,137

Million

Market Snapshot

Market Size in 2025 (Value)

US$ 5,185 million

Market Forecast in 2031(Value)

US$ 8,137 million

CAGR

7.8%

Years Considered

2020-2031

Base Year

2025

Forecast Period

2025-2031

Source: Secondary research, interviews with experts, and QYResearch analysis

The global market for Varicella Vaccine was valued at US$ 4845 million in the year 2024 and is projected to reach a revised size of US$ 8137 million by 2031, growing at a CAGR of 7.8% during the forecast period.

Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin

Global Varicella Vaccine key players include Merck, Shanghai Institute, Changsheng, Keygen, GSK, etc.

Asia is the largest market, with a share over 35%, followed by US and Europe, both have a share over 55%.

In terms of product, Freeze-Dried Powder is the largest segment, with a share over 50%. And in terms of application, the largest application is Kids Injection, followed by Adults Injection, etc.

biaoTi REPORT SCOPE

This report aims to provide a comprehensive presentation of the global market for Varicella Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Varicella Vaccine.

The Varicella Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Varicella Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Varicella Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

By Company

Merck

GSK

Shanghai Institute

BCHT

Changsheng

Keygen

Green Cross

Biken

Segment by Type

Injection

Freeze-Dried Powder

Segment by Application

Kids Injection

Adults Injection

Consumption by Region

North America

U.S.

Canada

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Europe

Germany

France

U.K.

Italy

Russia

Latin America

Mexico

Brazil

Argentina

Middle East and Africa

Turkey

Saudi Arabia

UAE

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Varicella Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Varicella Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Varicella Vaccine Market Overview

1.1 Product Definition

1.2 Varicella Vaccine by Type

1.2.1 Global Varicella Vaccine Market Value Comparison by Type (2024 VS 2031)

1.2.2 Injection

1.2.3 Freeze-Dried Powder

1.3 Varicella Vaccine by Application

1.3.1 Global Varicella Vaccine Market Value by Application (2024 VS 2031)

1.3.2 Kids Injection

1.3.3 Adults Injection

1.4 Global Varicella Vaccine Market Size Estimates and Forecasts

1.4.1 Global Varicella Vaccine Revenue 2020-2031

1.4.2 Global Varicella Vaccine Sales 2020-2031

1.4.3 Global Varicella Vaccine Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Varicella Vaccine Market Competition by Manufacturers

2.1 Global Varicella Vaccine Sales Market Share by Manufacturers (2020-2025)

2.2 Global Varicella Vaccine Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Varicella Vaccine Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Varicella Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Varicella Vaccine, Product Type & Application

2.7 Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry

2.8 Global Varicella Vaccine Market Competitive Situation and Trends

2.8.1 Global Varicella Vaccine Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Varicella Vaccine Players Market Share by Revenue

2.8.3 Global Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Varicella Vaccine Market Scenario by Region

3.1 Global Varicella Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Varicella Vaccine Sales by Region: 2020-2031

3.2.1 Global Varicella Vaccine Sales by Region: 2020-2025

3.2.2 Global Varicella Vaccine Sales by Region: 2026-2031

3.3 Global Varicella Vaccine Revenue by Region: 2020-2031

3.3.1 Global Varicella Vaccine Revenue by Region: 2020-2025

3.3.2 Global Varicella Vaccine Revenue by Region: 2026-2031

3.4 North America Varicella Vaccine Market Facts & Figures by Country

3.4.1 North America Varicella Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Varicella Vaccine Sales by Country (2020-2031)

3.4.3 North America Varicella Vaccine Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Varicella Vaccine Market Facts & Figures by Country

3.5.1 Europe Varicella Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Varicella Vaccine Sales by Country (2020-2031)

3.5.3 Europe Varicella Vaccine Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Varicella Vaccine Market Facts & Figures by Region

3.6.1 Asia Pacific Varicella Vaccine Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Varicella Vaccine Sales by Region (2020-2031)

3.6.3 Asia Pacific Varicella Vaccine Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Varicella Vaccine Market Facts & Figures by Country

3.7.1 Latin America Varicella Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Varicella Vaccine Sales by Country (2020-2031)

3.7.3 Latin America Varicella Vaccine Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Varicella Vaccine Market Facts & Figures by Country

3.8.1 Middle East and Africa Varicella Vaccine Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Varicella Vaccine Sales by Country (2020-2031)

3.8.3 Middle East and Africa Varicella Vaccine Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Varicella Vaccine Sales by Type (2020-2031)

4.1.1 Global Varicella Vaccine Sales by Type (2020-2025)

4.1.2 Global Varicella Vaccine Sales by Type (2026-2031)

4.1.3 Global Varicella Vaccine Sales Market Share by Type (2020-2031)

4.2 Global Varicella Vaccine Revenue by Type (2020-2031)

4.2.1 Global Varicella Vaccine Revenue by Type (2020-2025)

4.2.2 Global Varicella Vaccine Revenue by Type (2026-2031)

4.2.3 Global Varicella Vaccine Revenue Market Share by Type (2020-2031)

4.3 Global Varicella Vaccine Price by Type (2020-2031)

5 Segment by Application

5.1 Global Varicella Vaccine Sales by Application (2020-2031)

5.1.1 Global Varicella Vaccine Sales by Application (2020-2025)

5.1.2 Global Varicella Vaccine Sales by Application (2026-2031)

5.1.3 Global Varicella Vaccine Sales Market Share by Application (2020-2031)

5.2 Global Varicella Vaccine Revenue by Application (2020-2031)

5.2.1 Global Varicella Vaccine Revenue by Application (2020-2025)

5.2.2 Global Varicella Vaccine Revenue by Application (2026-2031)

5.2.3 Global Varicella Vaccine Revenue Market Share by Application (2020-2031)

5.3 Global Varicella Vaccine Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Merck Varicella Vaccine Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 GSK

6.2.1 GSK Company Information

6.2.2 GSK Description and Business Overview

6.2.3 GSK Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.2.4 GSK Varicella Vaccine Product Portfolio

6.2.5 GSK Recent Developments/Updates

6.3 Shanghai Institute

6.3.1 Shanghai Institute Company Information

6.3.2 Shanghai Institute Description and Business Overview

6.3.3 Shanghai Institute Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shanghai Institute Varicella Vaccine Product Portfolio

6.3.5 Shanghai Institute Recent Developments/Updates

6.4 BCHT

6.4.1 BCHT Company Information

6.4.2 BCHT Description and Business Overview

6.4.3 BCHT Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.4.4 BCHT Varicella Vaccine Product Portfolio

6.4.5 BCHT Recent Developments/Updates

6.5 Changsheng

6.5.1 Changsheng Company Information

6.5.2 Changsheng Description and Business Overview

6.5.3 Changsheng Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Changsheng Varicella Vaccine Product Portfolio

6.5.5 Changsheng Recent Developments/Updates

6.6 Keygen

6.6.1 Keygen Company Information

6.6.2 Keygen Description and Business Overview

6.6.3 Keygen Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Keygen Varicella Vaccine Product Portfolio

6.6.5 Keygen Recent Developments/Updates

6.7 Green Cross

6.7.1 Green Cross Company Information

6.7.2 Green Cross Description and Business Overview

6.7.3 Green Cross Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Green Cross Varicella Vaccine Product Portfolio

6.7.5 Green Cross Recent Developments/Updates

6.8 Biken

6.8.1 Biken Company Information

6.8.2 Biken Description and Business Overview

6.8.3 Biken Varicella Vaccine Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Biken Varicella Vaccine Product Portfolio

6.8.5 Biken Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Varicella Vaccine Industry Chain Analysis

7.2 Varicella Vaccine Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Varicella Vaccine Production Mode & Process Analysis

7.4 Varicella Vaccine Sales and Marketing

7.4.1 Varicella Vaccine Sales Channels

7.4.2 Varicella Vaccine Distributors

7.5 Varicella Vaccine Customer Analysis

8 Varicella Vaccine Market Dynamics

8.1 Varicella Vaccine Industry Trends

8.2 Varicella Vaccine Market Drivers

8.3 Varicella Vaccine Market Challenges

8.4 Varicella Vaccine Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Varicella Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Varicella Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Varicella Vaccine Market Competitive Situation by Manufacturers in 2024

Table 4. Global Varicella Vaccine Sales (M Doses) of Key Manufacturers (2020-2025)

Table 5. Global Varicella Vaccine Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Varicella Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Varicella Vaccine Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Varicella Vaccine Average Price (USD/Dose) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Varicella Vaccine, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Varicella Vaccine, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Varicella Vaccine, Product Type & Application

Table 12. Global Key Manufacturers of Varicella Vaccine, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Varicella Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Varicella Vaccine as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Varicella Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Varicella Vaccine Sales by Region (2020-2025) & (M Doses)

Table 18. Global Varicella Vaccine Sales Market Share by Region (2020-2025)

Table 19. Global Varicella Vaccine Sales by Region (2026-2031) & (M Doses)

Table 20. Global Varicella Vaccine Sales Market Share by Region (2026-2031)

Table 21. Global Varicella Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Varicella Vaccine Revenue Market Share by Region (2020-2025)

Table 23. Global Varicella Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Varicella Vaccine Revenue Market Share by Region (2026-2031)

Table 25. North America Varicella Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Varicella Vaccine Sales by Country (2020-2025) & (M Doses)

Table 27. North America Varicella Vaccine Sales by Country (2026-2031) & (M Doses)

Table 28. North America Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Varicella Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Varicella Vaccine Sales by Country (2020-2025) & (M Doses)

Table 32. Europe Varicella Vaccine Sales by Country (2026-2031) & (M Doses)

Table 33. Europe Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Varicella Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Varicella Vaccine Sales by Region (2020-2025) & (M Doses)

Table 37. Asia Pacific Varicella Vaccine Sales by Region (2026-2031) & (M Doses)

Table 38. Asia Pacific Varicella Vaccine Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Varicella Vaccine Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Varicella Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Varicella Vaccine Sales by Country (2020-2025) & (M Doses)

Table 42. Latin America Varicella Vaccine Sales by Country (2026-2031) & (M Doses)

Table 43. Latin America Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Varicella Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Varicella Vaccine Sales by Country (2020-2025) & (M Doses)

Table 47. Middle East and Africa Varicella Vaccine Sales by Country (2026-2031) & (M Doses)

Table 48. Middle East and Africa Varicella Vaccine Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Varicella Vaccine Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Varicella Vaccine Sales (M Doses) by Type (2020-2025)

Table 51. Global Varicella Vaccine Sales (M Doses) by Type (2026-2031)

Table 52. Global Varicella Vaccine Sales Market Share by Type (2020-2025)

Table 53. Global Varicella Vaccine Sales Market Share by Type (2026-2031)

Table 54. Global Varicella Vaccine Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Varicella Vaccine Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Varicella Vaccine Revenue Market Share by Type (2020-2025)

Table 57. Global Varicella Vaccine Revenue Market Share by Type (2026-2031)

Table 58. Global Varicella Vaccine Price (USD/Dose) by Type (2020-2025)

Table 59. Global Varicella Vaccine Price (USD/Dose) by Type (2026-2031)

Table 60. Global Varicella Vaccine Sales (M Doses) by Application (2020-2025)

Table 61. Global Varicella Vaccine Sales (M Doses) by Application (2026-2031)

Table 62. Global Varicella Vaccine Sales Market Share by Application (2020-2025)

Table 63. Global Varicella Vaccine Sales Market Share by Application (2026-2031)

Table 64. Global Varicella Vaccine Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Varicella Vaccine Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Varicella Vaccine Revenue Market Share by Application (2020-2025)

Table 67. Global Varicella Vaccine Revenue Market Share by Application (2026-2031)

Table 68. Global Varicella Vaccine Price (USD/Dose) by Application (2020-2025)

Table 69. Global Varicella Vaccine Price (USD/Dose) by Application (2026-2031)

Table 70. Merck Company Information

Table 71. Merck Description and Business Overview

Table 72. Merck Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 73. Merck Varicella Vaccine Product

Table 74. Merck Recent Developments/Updates

Table 75. GSK Company Information

Table 76. GSK Description and Business Overview

Table 77. GSK Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 78. GSK Varicella Vaccine Product

Table 79. GSK Recent Developments/Updates

Table 80. Shanghai Institute Company Information

Table 81. Shanghai Institute Description and Business Overview

Table 82. Shanghai Institute Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 83. Shanghai Institute Varicella Vaccine Product

Table 84. Shanghai Institute Recent Developments/Updates

Table 85. BCHT Company Information

Table 86. BCHT Description and Business Overview

Table 87. BCHT Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 88. BCHT Varicella Vaccine Product

Table 89. BCHT Recent Developments/Updates

Table 90. Changsheng Company Information

Table 91. Changsheng Description and Business Overview

Table 92. Changsheng Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 93. Changsheng Varicella Vaccine Product

Table 94. Changsheng Recent Developments/Updates

Table 95. Keygen Company Information

Table 96. Keygen Description and Business Overview

Table 97. Keygen Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 98. Keygen Varicella Vaccine Product

Table 99. Keygen Recent Developments/Updates

Table 100. Green Cross Company Information

Table 101. Green Cross Description and Business Overview

Table 102. Green Cross Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 103. Green Cross Varicella Vaccine Product

Table 104. Green Cross Recent Developments/Updates

Table 105. Biken Company Information

Table 106. Biken Description and Business Overview

Table 107. Biken Varicella Vaccine Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2020-2025)

Table 108. Biken Varicella Vaccine Product

Table 109. Biken Recent Developments/Updates

Table 110. Key Raw Materials Lists

Table 111. Raw Materials Key Suppliers Lists

Table 112. Varicella Vaccine Distributors List

Table 113. Varicella Vaccine Customers List

Table 114. Varicella Vaccine Market Trends

Table 115. Varicella Vaccine Market Drivers

Table 116. Varicella Vaccine Market Challenges

Table 117. Varicella Vaccine Market Restraints

Table 118. Research Programs/Design for This Report

Table 119. Key Data Information from Secondary Sources

Table 120. Key Data Information from Primary Sources

Table 121. Authors List of This Report

List of Figures

Figure 1. Product Picture of Varicella Vaccine

Figure 2. Global Varicella Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Varicella Vaccine Market Share by Type: 2024 & 2031

Figure 4. Injection Product Picture

Figure 5. Freeze-Dried Powder Product Picture

Figure 6. Global Varicella Vaccine Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Varicella Vaccine Market Share by Application: 2024 & 2031

Figure 8. Kids Injection

Figure 9. Adults Injection

Figure 10. Global Varicella Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Varicella Vaccine Market Size (2020-2031) & (US$ Million)

Figure 12. Global Varicella Vaccine Sales (2020-2031) & (M Doses)

Figure 13. Global Varicella Vaccine Average Price (USD/Dose) & (2020-2031)

Figure 14. Varicella Vaccine Report Years Considered

Figure 15. Varicella Vaccine Sales Share by Manufacturers in 2024

Figure 16. Global Varicella Vaccine Revenue Share by Manufacturers in 2024

Figure 17. Global 5 and 10 Largest Varicella Vaccine Players: Market Share by Revenue in Varicella Vaccine in 2024

Figure 18. Varicella Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 19. Global Varicella Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 20. North America Varicella Vaccine Sales Market Share by Country (2020-2031)

Figure 21. North America Varicella Vaccine Revenue Market Share by Country (2020-2031)

Figure 22. U.S. Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 23. Canada Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Europe Varicella Vaccine Sales Market Share by Country (2020-2031)

Figure 25. Europe Varicella Vaccine Revenue Market Share by Country (2020-2031)

Figure 26. Germany Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. France Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. U.K. Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Italy Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Russia Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Asia Pacific Varicella Vaccine Sales Market Share by Region (2020-2031)

Figure 32. Asia Pacific Varicella Vaccine Revenue Market Share by Region (2020-2031)

Figure 33. China Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Japan Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. South Korea Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. India Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Australia Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. China Taiwan Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. Indonesia Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Thailand Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Malaysia Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Latin America Varicella Vaccine Sales Market Share by Country (2020-2031)

Figure 43. Latin America Varicella Vaccine Revenue Market Share by Country (2020-2031)

Figure 44. Mexico Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Brazil Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Argentina Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Middle East and Africa Varicella Vaccine Sales Market Share by Country (2020-2031)

Figure 48. Middle East and Africa Varicella Vaccine Revenue Market Share by Country (2020-2031)

Figure 49. Turkey Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Saudi Arabia Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. UAE Varicella Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Global Sales Market Share of Varicella Vaccine by Type (2020-2031)

Figure 53. Global Revenue Market Share of Varicella Vaccine by Type (2020-2031)

Figure 54. Global Varicella Vaccine Price (USD/Dose) by Type (2020-2031)

Figure 55. Global Sales Market Share of Varicella Vaccine by Application (2020-2031)

Figure 56. Global Revenue Market Share of Varicella Vaccine by Application (2020-2031)

Figure 57. Global Varicella Vaccine Price (USD/Dose) by Application (2020-2031)

Figure 58. Varicella Vaccine Value Chain

Figure 59. Channels of Distribution (Direct Vs Distribution)

Figure 60. Bottom-up and Top-down Approaches for This Report

Figure 61. Data Triangulation

Figure 62. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which region is expected to have the highest market share? zhanKai

For each regional market, the report conducted in-depth comparative analysis from multiple dimensions such as market size, 7.8% compound annual growth rate, market demand, industrial structure, policy environment, and the layout of major enterprises. It systematically summarized the market characteristics and competitive environment of different regions. At the same time, it also focused on analyzing the demand structure, market growth drivers, and investment environment of each region, providing valuable references for enterprises to identify key regional markets, formulate global market layouts and sales strategies.

Which companies rank high in the global Varicella Vaccine market? shouQi

What is the annual compound growth rate of the global Varicella Vaccine market size from 2025 to 2031? shouQi

What was the global market size of Varicella Vaccine in 2031? shouQi

What was the global market size of Varicella Vaccine in 2025? shouQi

Related Reports

Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Varicella Vaccine market size was US$ 5185 million in 2025 and is forecast to reach a readjusted size of US$ 8708 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published Date: 2026-01-04
Pages: 79
USD 4250.00
(Single User License)
Global Varicella Vaccine Market Research Report 2026
The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 114
USD 2900.00
(Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Varicella Vaccine was estimated to be worth US$ 5185 million in 2025 and is projected to reach US$ 8708 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published Date: 2026-01-04
Pages: 96
USD 3950.00
(Single User License)
Global Varicella Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Varicella Vaccine market is projected to grow from US$ 4845 million in 2024 to US$ 8137 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 149
USD 4900.00
(Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 135
USD 5900.00
(Single User License)
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Varicella Vaccine market size was US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 77
USD 4250.00
(Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Varicella Vaccine was estimated to be worth US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 95
USD 3950.00
(Single User License)
Global Varicella Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-17
Pages: 140
USD 5600.00
(Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-16
Pages: 130
USD 5900.00
(Single User License)
Global Varicella Vaccine Market Insights, Forecast to 2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published Date: 2024-04-07
Pages: 87
USD 4900.00
(Single User License)

Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Varicella Vaccine market size was US$ 5185 million in 2025 and is forecast to reach a readjusted size of US$ 8708 million by 2032 with a CAGR of 7.8% during the forecast period 2026-2032.
Published: 2026-01-04
Pages: 79
USD 4250.00 (Single User License)
Global Varicella Vaccine Market Research Report 2026
The global Varicella Vaccine market was valued at US$ 5185 million in 2025 and is anticipated to reach US$ 8708 million by 2032, at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 114
USD 2900.00 (Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Varicella Vaccine was estimated to be worth US$ 5185 million in 2025 and is projected to reach US$ 8708 million, growing at a CAGR of 7.8% from 2026 to 2032.
Published: 2026-01-04
Pages: 96
USD 3950.00 (Single User License)
Global Varicella Vaccine Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Varicella Vaccine market is projected to grow from US$ 4845 million in 2024 to US$ 8137 million by 2031, at a CAGR of 7.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 149
USD 4900.00 (Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Varicella Vaccine was estimated to be worth US$ 4845 million and is forecast to reach approximately US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 135
USD 5900.00 (Single User License)
Global Varicella Vaccine Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Varicella Vaccine market size was US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 77
USD 4250.00 (Single User License)
Varicella Vaccine- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Varicella Vaccine was estimated to be worth US$ 4845 million in 2024 and is forecast to a readjusted size of US$ 8137 million by 2031 with a CAGR of 7.8% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 95
USD 3950.00 (Single User License)
Global Varicella Vaccine Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-17
Pages: 140
USD 5600.00 (Single User License)
Global Varicella Vaccine Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-16
Pages: 130
USD 5900.00 (Single User License)
Global Varicella Vaccine Market Insights, Forecast to 2030
Varicella vaccine, also known as chickenpox vaccine, is a vaccine that protects against chickenpox. One dose of vaccine prevents 95% of moderate disease and 100% of severe disease. Two doses of vaccine is more effective than one. If given to those who are not immune within five days of exposure to chickenpox it prevents most cases of disease. Vaccinating a large portion of the population also protects those who are not vaccinated. It is given by injection just under the skin
Published: 2024-04-07
Pages: 87
USD 4900.00 (Single User License)